Choosing the right respiratory reporting platform is one of the most consequential decisions a clinical physiology lab can make. Rezibase is a cloud-based, vendor-neutral respiratory and sleep reporting system built by respiratory scientists, designed to eliminate double data entry, reduce clinical risk, and keep pace with evolving ATS standards. For labs evaluating their options in 2026, the platform offers an all-inclusive, no lock-in model that covers both respiratory and sleep reporting under one roof.

TL;DR

• Rezibase is built by respiratory scientists for respiratory scientists, making it purpose-built for clinical physiology workflows.

• It covers both respiratory and sleep lab management software needs in a single, cloud-based platform.

• Switching from Respiro to Rezibase is straightforward, with guided data migration support.

• No vendor lock-in, no server management, and a 30-day free trial make the transition low-risk.

• Rezibase is trusted by over 35 sites including NHS and NSW Health.

About the Author: This article was written by the Rezibase team at Cardiobase, a healthcare technology company with over 37 years of experience in clinical physiology software and a specialised focus on respiratory and sleep lab solutions across Australia, New Zealand, the UK, and Ireland.

Why Does Platform Choice Matter So Much for Respiratory Labs?

The wrong platform does not just slow your team down. It creates clinical risk. Manual data re-entry, outdated normal values, and systems that cannot integrate with your hospital's Patient Administration System (PAS) or EMR all introduce opportunities for error. According to Cardiobase, Rezibase was developed over eight years by experienced respiratory scientists specifically to address these frustrations: clunky software, vendor lock-in, and platforms that fail to keep up with evolving standards.

For labs managing high patient volumes, the stakes are even higher. The CDC's 2025-2026 Respiratory Disease Season Outlook highlights ongoing national monitoring of respiratory illness trends, a reminder that respiratory labs remain on the frontline of public health. Having a platform that can scale, integrate, and report accurately is not optional.

What Is Respiro and Who Uses It?

Respiro is an established respiratory reporting platform used by a number of clinical physiology labs, particularly in Australia. It has historically served labs that need structured reporting workflows and integration with hospital systems. Many labs have used it for years and have built their processes around it.

However, some labs using Respiro have reported limitations around:

• Cloud accessibility and the burden of local server management

• Time consuming managing software updates

• Open source integration engine Mirth is no longer open source

• Coverage of sleep reporting alongside respiratory reporting

These are not trivial concerns. They affect daily workflow, accreditation readiness, and the ability to adapt as technology evolves.

Note: A detailed feature-by-feature comparison of Rezibase and Respiro is available upon request and subject to review. Contact the Rezibase team at rezibase.com for a tailored assessment.

What Makes Rezibase Different From Other Respiratory Platforms?

Rezibase's core differentiator is simple: it was made by respiratory scientists, not software developers trying to interpret clinical needs from the outside. Founded by Peter Rochford and the late Jeff Pretto, the platform reflects decades of real-world lab experience.

Key differentiators include:

The platform also covers the full patient lifecycle: referrals, electronic ordering, waitlist management, eforms, bookings, rostering, and billing. For labs looking for a single solution rather than a patchwork of tools, this breadth matters.

How Hard Is It to Switch From Respiro to Rezibase?

This is the question most labs ask first, and the honest answer is: it is more manageable than you might expect.

Switching platforms feels daunting because of historical data, staff retraining, and workflow disruption. Rezibase is designed to make this transition as smooth as possible:

• Data migration is guided. The Rezibase team works with your lab to move existing records across without starting from scratch.

• The interface is built for scientists. Because it was designed by people who have worked in labs, the learning curve reflects real workflows rather than generic software logic.

• Cloud deployment means no infrastructure overhaul. There is no new server to install or IT project to manage. If you have an internet connection, you are ready.

• The 30-day free trial lets you test before committing. Your team can explore the platform with your own use cases before making any decision.

The goal is continuity of care, not disruption. Labs that have made the switch have been able to maintain reporting standards throughout the transition.

Does Rezibase Support Sleep Lab Management Software Needs?

Yes, and this is one of the areas where Rezibase stands apart from platforms that focus exclusively on respiratory reporting. Many labs run respiratory and sleep services under the same roof, yet are forced to use separate systems for each, creating duplication, integration headaches, and additional licensing costs.

Rezibase covers both disciplines in a single platform. Sleep lab management software functionality is built into the same environment as respiratory reporting, meaning:

• Shared patient records across respiratory and sleep

• Unified booking and rostering for both departments

• Consistent accreditation documentation covering both service areas

• One support relationship, one contract, one platform

For labs managing both services, this consolidation alone can justify the switch.

Is Rezibase Suitable for NHS and Public Hospital Environments?

Yes. Rezibase is already trusted by NHS sites in the UK and NSW Health in Australia, demonstrating that the platform meets the governance, integration, and compliance requirements of large public health systems. It integrates with PAS, EMR, DICOM Modality Worklists, Hospital Finance Systems, and Electronic Orders Systems, which are the integration points that matter most in public hospital environments.

For private clinics, the same platform scales down without losing functionality, making it equally suited to smaller, independent labs.

Frequently Asked Questions

Is Rezibase only for Australian labs?
No. Rezibase is used across Australia, New Zealand, the UK, and Ireland, including NHS sites.

What happens to our existing data if we switch from Respiro?
The Rezibase team provides guided data migration support to help move your existing records across. The process is designed to be straightforward and minimise disruption.

Does Rezibase require us to use specific equipment manufacturers?
No. Rezibase is fully vendor-neutral. The Magic Import feature allows data import from any device manufacturer.

How is Rezibase priced?
Rezibase uses a transparent, all-inclusive monthly pricing model with no lock-in contracts and a 30-day free trial.

Does Rezibase help with accreditation?
Yes. The accreditation module covers TSANZ/NATA Standards and ISO 15189 requirements, including documents, training, non-conformance, action plans, audits, and quality control.

Can Rezibase be deployed on-premises?
Yes. While Rezibase is primarily a cloud-based SaaS platform, enterprise on-premises deployment is available for hospitals with specific infrastructure requirements.

How long does implementation typically take?
Implementation timelines vary depending on lab size and integration requirements. The Rezibase team works with each site individually to plan a realistic and supported rollout.

About Rezibase

Rezibase is Australia's most advanced respiratory and sleep reporting platform, developed over eight years by experienced respiratory scientists and now backed by Cardiobase, a healthcare technology company with 37 years of clinical physiology expertise. The platform serves over 35 sites across Australia, New Zealand, the UK, and Ireland, including NHS and NSW Health. Rezibase's mission is to improve patient care through technology by making life genuinely easier for the scientists who deliver it every day.

Ready to see Rezibase in action? Visit rezibase.com to start your 30-day free trial or speak with the team about your lab's specific needs.

References

• Cardiobase. Rezibase. https://www.cardiobase.com/rezibase

• CDC. 2025-2026 Respiratory Disease Season Outlook - December Update. https://www.cdc.gov/cfa-qualitative-assessments/php/data-research/season-outlook25-26-dec-update.html